Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 387 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology. Provides the latest information on cancer researchOffers outstanding and original reviews on a range of cancer research topicsServes as an indispensable reference for researchers and students alike INDICE: 1. Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utilityGiulia Bertolini and Giuseppe Lo Russo2. Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical OutcomesLamiaa El-Shennawy3. CTCs in CRC: updatesPashtoon Kasi4. Proteomics and post-translational modification analysis in CTCsHuiping Liu5. Latest advances of CTC studies in prostate cancerParaskevi Giannakakou6. Epigenetics and CTCs: new biomarkers and impact on tumor biologyEVRYKLEIA LIANIDOU and Aliki Ntzifa

• ISBN: 978-0-443-13655-9
• Editorial: Academic Press
• Encuadernacion: Cartoné
• Páginas: 277
• Fecha Publicación: 01/10/2024
• Nº Volúmenes: 1
• Idioma: Inglés